跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
HYPERRAB 300 UI/ML SOLUCION INYECTABLE
Approved
STANDARD
HYPERRAB 300 UI/ML SOLUCION INYECTABLE
Instituto Grifols S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 29, 2024
Approval ID
4ad70edf5cc27993
Company
Instituto Grifols S.A.
Type
Standard
Approval Details
Approval Id
4ad70edf5cc27993
Drug Cima Aemps Name
HYPERRAB 300 UI/ML SOLUCION INYECTABLE
Register Number
89740
Holder Company Name
Instituto Grifols S.A.
Marketing Company Name
Instituto Grifols S.A.
Holder Company Detail Path
/organization/instituto-grifols-sa
Marketing Company Detail Path
/organization/instituto-grifols-sa
Authorization Date
2024-07-29
Dosage Form
SOLUCIÓN INYECTABLE
Dose
300 IU/ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Instituto Grifols S.A.
Company Detail Path
/organization/instituto-grifols-sa
Company Information
Pharmaceutical Company Name
INSTITUTO GRIFOLS SA
Country Name
Spain
City Name
parets del valles,barcelona,country_es
Address
CALLE CAN GUASCH (PG LEVANTE) 2
Active Ingredients
INMUNOGLOBULINA HUMANA ANTIRRABICA
300 UI/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 29, 2024
Approval ID
4ad70edf5cc27993
Type
Standard
Back to CIMA-AEMPS Approvals